This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Allscripts Professional EHR™ 13.0 Is Generally Available

CHICAGO, Sept. 3, 2013 /PRNewswire/ -- Allscripts (NASDAQ: MDRX) announced today that Allscripts Professional™ Electronic Health Record (EHR) 13.0 is now generally available. The release of Allscripts Professional EHR 13.0 is part of the company's ongoing client commitment to provide the tools needed to help them achieve Meaningful Use Stages 1 and 2. 

"Allscripts Professional EHR 13.0 is a reflection of our unwavering commitment to our clients," said Paul M. Black, President and Chief Executive Officer of Allscripts. "This new version of Professional is a more powerful and more complete solution, with exceptional function and features."

Allscripts Professional EHR 13.0 was certified for meeting ONC 2014 Edition Standards & Certification Criteria set by the Certification Commission for Health Information Technology (CCHIT®). ONC 2014 certification supports both Stage 1 and Stage 2 Meaningful Use, requiring EHR solutions have the capabilities that clients need to meet their attestation goals and clinical measures.

Intuitive operation, improved billing capabilities and specialty-specific clinical content makes Allscripts Professional the solution of choice for solo practitioners as well as mid-sized, multispecialty practices. Allscripts Professional EHR 13.0 has a number of important enhancements and features, including:
  • Meaningful Use Stage 2 Compliance: Allscripts Professional has achieved complete and modular ONC 2014 certification, confirming that Allscripts Professional has the capabilities required for current Meaningful Use Stage 1 criteria and future Stage 2 criteria.
  • Patient Portal Integration: Allscripts Professional can send and receive secure messages with patients through full patient portal integration. Allscripts Professional is integrated with FollowMyHealth™ and Intuit Patient Portals, enabling messaging between patients and providers. Integration with a full patient portal is required for meeting Meaningful Use Stage 2 standards.

In addition, Allscripts Professional 13.0 also includes enhancements to core EHR functionality which can help clients increase user efficiency and improve day-to-day use, including the following capabilities:
  • Bi-Directional Immunizations: Receive immunization data from state immunization registries that are capable of exchanging data with practices. 
  • Care Plans and Goals: Build care plans, set goals, track patient progress, and identify barriers through the core EHR solution.
  • InfoButton Technology: Context sensitive patient education and referential decision support are now available through InfoButton technology.

To complement Allscripts Professional EHR 13.0, and to help position practices to attain Meaningful Use, Allscripts offers multiple service options:
  • Remote Assessments are available for all stages of Meaningful Use: Stage one, year one; stage one, year two; and stage two.
  • Onsite Consultative Services are also available, including Meaningful Use Attestation Readiness Validation, which features a comprehensive assessment of a practice's needs for Meaningful Use readiness.

About Allscripts Allscripts (NASDAQ:  MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a  Connected Community of Health™ for physicians, hospitals and post-acute organizations.  To learn more about Allscripts, please visit, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2013 Allscripts Healthcare, LLC. All Rights Reserved.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs